Vanderbeke, L ;
Janssen, N.A.F ;
Bergmans, D.C.J.J...
Vanderbeke , L , Janssen , N A F , Bergmans , D C J J , Bourgeois , M , Buil , J B , Debaveye , Y , Depuydt , P , Feys , S , Hermans , G , Hoiting , O , van der Hoven , B , Jacobs , C , Lagrou , K , Lemiale , V , Lormans , P , Maertens , J , Meersseman , P , Megarbane , B , Nseir , S , van Oers , J A H , Reynders , M , Rijnders , B J A , Schouten , J A , Spriet , I , Thevissen , K , Thille , A W , Van Daele , R , van de Veerdonk , F L , Verweij , P E , Wilmer , A , Bruggemann , R J M , Wauters , J & Dutch Belgian Mycosis Study Grp 2021 , ' Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial ' , Intensive Care Medicine , vol. 47 , no. 6 , pp. 674-686 . https://doi.org/10.1007/s00134-021-06431-0.
,
2021
